TORRENT PHARMACEUTICALS L financial statements, including revenue, expenses, and profit
The total revenue of TORNTPHARM for the last quarter is 28.09 B INR, and it's 2.77% lower compared to the previous quarter. The net income of Q3 24 is 5.03 B INR.